• Six Years in the Making: New Episodic Migraine Guidelines Six Years in the Making: New Episodic Migraine Guidelines What herb has level A evidence for migraine relief? What drug is commonly underdosed? Find out as Dr. Andrew Wilner interviews Dr. David Dodick about the AAN's new migraine clinical guidelines.
  • Top News From AAN 2012: Slideshow Top News From AAN 2012: Slideshow Highlights from the meeting include a new guideline for the prevention of episodic migraine, more positive results with BG-12 for MS, and the IMS 3 stroke trial was halted.
  • Closure on CLOSURE for Patent Foramen Ovale? Closure on CLOSURE for Patent Foramen Ovale?   Is PFO closure more beneficial than medical therapy in patients with cryptogenic stroke? Dr. Mark Alberts describes the results of the CLOSURE study.
  • Four Upcoming Breakthroughs in Neurology? Four Upcoming Breakthroughs in Neurology? Medscape interviews AAN Science Editor José Merino, MD, on potentially impactful data presented at this year's Annual Meeting.
 
 

Neurology News
 – From Medscape Medical News, theheart.org, and more

  • Lifetime Prevalence of Sleepwalking Almost 30% Lifetime Prevalence of Sleepwalking Almost 30% Use of hypnotic sleeping medications doesn't significantly increase risk for sleepwalking, but comorbid major depression, obsessive-compulsive disorder, or alcohol abuse does.
  • Are Fewer People Developing Dementia? Are Fewer People Developing Dementia? New data suggest that the incidence of dementia is declining, perhaps in part because of better control of vascular risk factors.
AAN 2012
 

Neurology Perspectives

Physician Compensation Report 2012
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC. This website also contains material copyrighted by 3rd parties.